Biokine Therapeutics
2000
FOUNDED
M&A
STATUS
2ndary - Open
LATEST DEAL TYPE
(Announced)
6
INVESTORS
Description
Developer of novel drugs designed to identifying novel molecular and cellular mechanisms that regulate tumor development and metastasis. The company's novel drugs offers cancer treatment, mainly leukemia and myeloma, enabling healthcare industries to develop novel therapeutics against these devastating diseases.
Website
Ownership Status
Acquired/Merged
(Operating Subsidiary)
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Office
- Weizmann Science Park
- PO Box: 2213
- Rehovot 76120
- Israel
+972 00-000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Biokine Therapeutics’s full profile, request a free trial.
Biokine Therapeutics Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Secondary Transaction - Open Market | 03-Oct-2018 | Announced | Generating Revenue | |||
| 5. Merger/Acquisition | 00000 | Completed | Generating Revenue | |||
| 4. Grant | 18-Mar-2009 | 00.00 | 00000 | Completed | Generating Revenue | |
| 3. Later Stage VC | 10-Jan-2007 | 00000 | 00000 | Completed | Generating Revenue | |
| 2. Grant | $600K | Completed | Startup | |||
| 1. Accelerator/Incubator | 01-Jul-2000 | Completed | Startup |
Biokine Therapeutics Executive Team (4)
| Name | Title | Board Seat |
Contact Info |
|---|---|---|---|
| Amnon Peled Ph.D | Co-Founder, Chief Executive Officer, Chief Scientific Officer & Board Member | ||
| Orly Eizenberg Ph.D | Co-Founder & Vice President, Research & Development |
2 Former Executives
You’re viewing 2 of 4 executives. Get the full list »Biokine Therapeutics Board Members (6)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Amnon Peled Ph.D | Biokine Therapeutics | Co-Founder, Chief Executive Officer, Chief Scientific Officer & Board Member | 000 0000 | |
| Anthony Stanton | Self | Board Member | 000 0000 | |
| H. Laurence Shaw MD | Self | Chairman | 000 0000 | |
| Ofer Goldberg | Clal Biotechnology Industries | Board Member | 000 0000 | |
| Shmuel Cabilly | Self | Board Member | 000 0000 |